IDEXX Laboratories: Cancer Dx Launch In March 2025; Upgrading To 'Buy'
IDEXX Laboratories' oncology panel and share buybacks boost outlook. Read why IDXX stock is upgraded to buy with growth ...
The Manila Times4 天
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and ...
The latest HPRA inspection in February 2025 was highly successful-both QC licences were renewed, and viral vector manufacturing was added to the MIA (IMP) licence. This means the Shannon site can ...
Eve Holding projects first eVTOL flight by mid-2025 with $14B pre-order backlog
Explore Eve Holding's Q4 2024 earnings call highlights, featuring eVTOL milestones, $429M liquidity, $14B pre-order backlog, and 2027 certification goals.